מצרים - אנגלית - EDA (Egyptian Drug Authority)

alcon-scientific office - eye drops - 0.3 %

סינגפור - אנגלית - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - tobramycin - ointment - 3 mg/g - tobramycin 3 mg/g

איחוד האמירויות הערביות - אנגלית - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

5 ml dropper bottle -

קנדה - אנגלית - Health Canada

novartis pharmaceuticals canada inc - tobramycin - solution - 0.3% - tobramycin 0.3% - antibacterials

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

tobramycin -

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - dexamethasone 0.1%{relative};  ; tobramycin 0.3%{relative} - eye drops, suspension - active: dexamethasone 0.1%{relative}   tobramycin 0.3%{relative} excipient: benzalkonium chloride disodium edetate dihydrate hyetellose purified water sodium chloride sodium hydroxide sodium sulfate sulfuric acid tyloxapol - tobradex ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns or penetration of foreign bodies. the use of a combination medicine with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.

ניגריה - אנגלית - NAFDAC (National Agency for Food and Drugs Administration and Control)

tobramycin 0.3%

קנדה - אנגלית - Health Canada

novartis pharmaceuticals canada inc - tobramycin - solution - 0.3% - tobramycin 0.3% - antibacterials

ארצות הברית - אנגלית - NLM (National Library of Medicine)

alcon laboratories, inc. - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobrex® (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex (tobramycin ophthalmic ointment) 0.3%. clinical studies have shown tobramycin to be safe and effective for use in children. tobrex (tobramycin ophthalmic ointment) 0.3 % is contraindicated in patients with known hypersensitivity to any of its components.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobrex® (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex (tobramycin ophthalmic ointment) 0.3%. clinical studies have shown tobramycin to be safe and effective for use in children. tobrex (tobramycin ophthalmic ointment) 0.3 % is contraindicated in patients with known hypersensitivity to any of its components.